NCT06040970 2025-12-02Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial CancerIcahn School of Medicine at Mount SinaiPhase 1/2 Recruiting54 enrolled